Log In
Print
BCIQ
Print
Print this Print this
 

Opsumit, macitentan (formerly ACT-064992, Actelion-1)

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionTissue-targeting endothelin receptor antagonist
Molecular Target Endothelin receptor
Mechanism of ActionEndothelin receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today